Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1247212.RAb8JE13q7ZR1TG6BLdL384STxQSN-DqHveTJD5vedzFk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1247212.RAb8JE13q7ZR1TG6BLdL384STxQSN-DqHveTJD5vedzFk130_assertion type Assertion NP1247212.RAb8JE13q7ZR1TG6BLdL384STxQSN-DqHveTJD5vedzFk130_head.
- NP1247212.RAb8JE13q7ZR1TG6BLdL384STxQSN-DqHveTJD5vedzFk130_assertion description "[In adulthood, X-ALD most commonly manifests as a gradually progressive myelopathy (adrenomyeloneuropathy; AMN) without any curative or disease modifying treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1247212.RAb8JE13q7ZR1TG6BLdL384STxQSN-DqHveTJD5vedzFk130_provenance.
- NP1247212.RAb8JE13q7ZR1TG6BLdL384STxQSN-DqHveTJD5vedzFk130_assertion evidence source_evidence_literature NP1247212.RAb8JE13q7ZR1TG6BLdL384STxQSN-DqHveTJD5vedzFk130_provenance.
- NP1247212.RAb8JE13q7ZR1TG6BLdL384STxQSN-DqHveTJD5vedzFk130_assertion SIO_000772 25499606 NP1247212.RAb8JE13q7ZR1TG6BLdL384STxQSN-DqHveTJD5vedzFk130_provenance.
- NP1247212.RAb8JE13q7ZR1TG6BLdL384STxQSN-DqHveTJD5vedzFk130_assertion wasDerivedFrom befree-2016 NP1247212.RAb8JE13q7ZR1TG6BLdL384STxQSN-DqHveTJD5vedzFk130_provenance.
- NP1247212.RAb8JE13q7ZR1TG6BLdL384STxQSN-DqHveTJD5vedzFk130_assertion wasGeneratedBy ECO_0000203 NP1247212.RAb8JE13q7ZR1TG6BLdL384STxQSN-DqHveTJD5vedzFk130_provenance.